Targeting epigenetic and DNA topology mechanisms: histone deacetylases and topoisomerase inhibitors in combination and dual inhibition approaches

PHARMACOLOGICAL REPORTS · Published 2026-05-28 · DOI 10.1007/s43440-026-00868-0

Free full text

Authors (5)

Yashaswini Reddy, Vyasraj G Bhat, Mukirala Vasanth Kumar, Ipshita Das, Babitha Kampa Sundara

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Reddy, Y., Bhat, V., Kumar, M., et al. (2026). Targeting epigenetic and DNA topology mechanisms: histone deacetylases and topoisomerase inhibitors in combination and dual inhibition approaches. PHARMACOLOGICAL REPORTS. https://doi.org/10.1007/s43440-026-00868-0

Related articles

• Diurnal variation of cisplatin-induced anti-tumor effect and renal toxicity in mice bearing human colon cancer cells · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Targeting mitochondrial deubiquitinase USP30 to induce mitophagy in heteroplasmic mitochondrial diseases · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Potential antidepressant properties of aminophylline in male mice exposed to chronic restraint stress · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• The effect of salidroside, an active component of Rhodiola rosea, on the metabolic activity of rat and human cytochromes P450 in preclinical studies · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Cannabidiol (CBD) modulates the serotonin–kynurenine metabolic balance in the brain of morphine-tolerant neuropathic rats · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Kisspeptin-10 regulates glycosaminoglycan and decorin content in human cardiac fibroblast cultures · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022–2024) · PHARMACOLOGICAL REPORTS · 2026 · Same journal
• CC8, a heterodimeric disintegrin from Cerastes cerastes snake venom, triggers apoptosis and restrains the dissemination of human glioblastoma cells · PHARMACOLOGICAL REPORTS · 2026 · Same journal